NANOVIRICIDES, INC. - 8-K Filing
Nanoviricides, Inc. entered into a securities purchase agreement on May 15, 2026, with an investor to raise approximately $2.0 million in gross proceeds through the sale of common stock and warrants. The offering included 1,133,334 shares at $1.50 per share, pre-funded warrants for 200,000 shares, and accompanying common warrants exercisable at $1.75 per share. The company intends to use the proceeds for working capital, R&D, clinical trials, and strategic acquisitions. (Items: 1.01 Entry into a Material Definitive Agreement, 8.01 Other Events, 9.01 Financial Statements and Exhibits (a) Exhibits Number Description 4)
Tickers: $NNVC